Baird Financial Group, Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,453,350
-21.5%
40,944
-5.6%
0.01%
-12.5%
Q2 2023$3,126,688
+415.5%
43,366
+426.0%
0.01%
+700.0%
Q1 2023$606,502
+254732.8%
8,245
+131.5%
0.00%0.0%
Q4 2022$238
-99.9%
3,561
-5.4%
0.00%0.0%
Q3 2022$324,000
-1.8%
3,763
+1.8%
0.00%0.0%
Q2 2022$330,000
-15.6%
3,698
+6.3%
0.00%0.0%
Q1 2022$391,000
-28.3%
3,479
-1.4%
0.00%0.0%
Q4 2021$545,000
-17.2%
3,527
-25.3%
0.00%
-50.0%
Q3 2021$658,000
+32.1%
4,720
+24.3%
0.00%
+100.0%
Q2 2021$498,000
-29.9%
3,796
-18.5%
0.00%
-50.0%
Q1 2021$710,000
+48.5%
4,655
-3.1%
0.00%
+100.0%
Q4 2020$478,000
+1.7%
4,804
-2.5%
0.00%
-50.0%
Q3 2020$470,000
-34.1%
4,929
-22.7%
0.00%
-33.3%
Q2 2020$713,000
+75.6%
6,377
+14.3%
0.00%
+50.0%
Q1 2020$406,000
-45.9%
5,577
-22.5%
0.00%
-33.3%
Q4 2019$751,000
-75.4%
7,197
-76.5%
0.00%
-75.0%
Q3 2019$3,050,000
-10.9%
30,637
+2.1%
0.01%
-7.7%
Q2 2019$3,425,00030,0040.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders